SEC 13F Intelligence

Managers / Q2 2021 · view latest →

SECTORAL ASSET MANAGEMENT INC

CIK 0001274413 · 1010 SHERBROOKE ST., WEST, SUITE 1610, MONTREAL, A8, H3A 2R7 · 514 849 8777

Reported Value
$1.2B
Q2 2021
Positions
127
Filings on Record
30
2019–present window
Filed
Aug 16, 2021
original filing

Summary

Sectoral Asset Management Inc reported $1.2B in U.S.-listed holdings across 127 positions for Q2 2021.

Its largest position, TFX, represents 2.6% of the portfolio.

Compared with Q1 2021, the fund opened 26 new positions and exited 12.

Portfolio Metrics

Turnover
+26.9%
vs prior filed quarter
Top-10 Concentration
+21.3%
share of reported value
Largest Position
+2.6%
Teleflex Incorporated
New / Exited
26 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $736MQ4 ’18Q1 ’19: $831MQ2 ’19: $836MQ3 ’19: $580MQ4 ’19: $670MQ4 ’19Q1 ’20: $521MQ2 ’20: $1.1BQ3 ’20: $1.2BQ4 ’20: $1.4BQ4 ’20Q1 ’21: $1.3BQ2 ’21: $1.2BQ3 ’21: $1.2BQ4 ’21: $664MQ4 ’21Q1 ’22: $563MQ2 ’22: $496MQ3 ’22: $508MQ4 ’22: $517MQ4 ’22Q1 ’23: $520MQ2 ’23: $600MQ3 ’23: $514MQ4 ’23: $232MQ4 ’23Q1 ’24: $254MQ2 ’24: $246MQ3 ’24: $169MQ4 ’24: $150MQ4 ’24Q1 ’25: $128MQ2 ’25: $151MQ3 ’25: $162MQ4 ’25: $125MQ4 ’25Q1 ’26: $121Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 79.4%Other: 20.3%ADR: 0.4%
  • Common Stock · 79.4% · $981M
  • Other · 20.3% · $250M
  • ADR · 0.4% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
8INSYNEOS HEALTH INCNEW+271.2K271.2K+$24M$24M
AXNX*AXONICS INCNEW+368.6K368.6K+$23M$23M
AVAHAVEANNA HEALTHCARE HLDGS INCNEW+1.66M1.66M+$21M$21M
CONVEY HLDG PARENT INCNEW+1.75M1.75M+$20M$20M
AGILITI INCNEW+828.4K828.4K+$18M$18M
BRIGHT HEALTH GROUP INCNEW+912.0K912.0K+$16M$16M
AEROVATE THERAPEUTICS INCNEW+500.0K500.0K+$11M$11M
CODEX DNA INCNEW+516.3K516.3K+$11M$11M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TFXTELEFLEX INCORPORATEDhistory →COM2.58%$32M79.4K
2EVHEVOLENT HEALTH INChistory →CL A2.52%$31M1.47M
3ATRCATRICURE INChistory →COM2.42%$30M376.6K
4ORTHO CLINICAL DIAGNOSTICS HORD SHS2.23%$28M1.29M
5IM8NINSMED INChistory →COM PAR $.012.10%$26M913.7K
6RCMEURR1 RCM INChistory →COM2.04%$25M1.14M
78INSYNEOS HEALTH INChistory →CL A1.96%$24M271.2K
8AXNX*AXONICS INChistory →COM1.89%$23M368.6K
9ARNAEURARENA PHARMACEUTICALS INChistory →COM NEW1.78%$22M322.6K
10ARVNARVINAS INChistory →COM1.76%$22M282.8K
11AG8AGILENT TECHNOLOGIES INChistory →COM1.75%$22M146.2K
12OLINK HLDG ABSPONSORED ADS1.71%$21M614.0K
13RGENREPLIGEN CORPhistory →COM1.69%$21M104.8K
14RCKTROCKET PHARMACEUTICALS INChistory →COM1.68%$21M470.1K
15ARQTARCUTIS BIOTHERAPEUTICS INChistory →COM1.68%$21M758.8K
16AVAHAVEANNA HEALTHCARE HLDGS INChistory →COM1.66%$21M1.66M
17AM6AMICUS THERAPEUTICS INChistory →COM1.63%$20M2.09M
18CONVEY HLDG PARENT INCCOM1.61%$20M1.75M
19BBIOBRIDGEBIO PHARMA INChistory →COM1.61%$20M325.9K
20ALHCALIGNMENT HEALTHCARE INChistory →COM1.60%$20M846.0K
21NVV1NOVAVAX INChistory →COM NEW1.52%$19M88.5K
22OAK STR HEALTH INCCOM1.52%$19M320.4K
23RCUSARCUS BIOSCIENCES INChistory →COM1.50%$19M674.3K
24AGILITI INCCOM1.47%$18M828.4K
25TURNING POINT THERAPEUTICS ICOM1.34%$17M211.7K
26TGTXTG THERAPEUTICS INChistory →COM1.30%$16M414.9K
27RMERESMED INChistory →COM1.30%$16M65.1K
28HORIZON THERAPEUTICS PUB LSHS1.29%$16M170.7K
29BRIGHT HEALTH GROUP INCCOM1.27%$16M912.0K
30AFWALIGN TECHNOLOGY INChistory →COM1.26%$16M25.4K
31ZBHZIMMER BIOMET HOLDINGS INChistory →COM1.15%$14M88.6K
32PTCTPTC THERAPEUTICS INChistory →COM1.14%$14M332.3K
33INVITAE CORPCOM1.12%$14M410.8K
34OLMAOLEMA PHARMACEUTICALS INChistory →COM1.11%$14M490.0K
35ALNYALNYLAM PHARMACEUTICALS INChistory →COM1.07%$13M77.8K
36NKTXNKARTA INChistory →COM1.05%$13M410.6K
37INSPINSPIRE MED SYS INChistory →COM1.05%$13M67.3K
38RPTXREPARE THERAPEUTICS INChistory →COM1.04%$13M412.1K
39FATEFATE THERAPEUTICS INChistory →COM1.03%$13M147.0K
40ACCDUSDACCOLADE INChistory →COM1.01%$12M230.0K
41JNJJOHNSON & JOHNSONhistory →COM0.97%$12M72.5K
42AVIRATEA PHARMACEUTICALS INChistory →COM0.94%$12M538.9K
43UNHUNITEDHEALTH GROUP INChistory →COM0.93%$12M28.8K
44AEROVATE THERAPEUTICS INCCOM0.92%$11M500.0K
45CODEX DNA INCCOM0.92%$11M516.3K
46CNCCENTENE CORP DELhistory →COM0.91%$11M154.0K
47NPCENEUROPACE INChistory →COM0.91%$11M472.0K
48DC4DEXCOM INChistory →COM0.91%$11M26.3K
49ABTABBOTT LABShistory →COM0.88%$11M93.9K
50SGENUSDSEAGEN INChistory →COM0.87%$11M68.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$121M77May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$125M74Feb 9, 202613F-HRchanges · EDGAR ↗
Q3 2025$162M82Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$151M94Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$128M84May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$150M86Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$169M90Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$246M97Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$254M92May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$232M104Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$514M123Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$600M121Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$520M118May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$517M120Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$508M109Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$496M112Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$563M106May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$664M108Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.2B127Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.2B127Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.3B113May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.4B97Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.2B88Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B191Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$521M65May 13, 202013F-HRchanges · EDGAR ↗
Q4 2019$670M65Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$580M63Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$836M92Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$831M106May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$736M104Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.